Find clinical trials for Prostate Cancer in Hanyang, Seoul
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Hanyang, Seoul, KOR:
8 weeks (±2 weeks) to patients with metastatic castration resistant prostate cancer (mCRPC) in order to assess the safety and effic...
Phase 2
Seoul, Korea, Republic of
with high-risk and very high-risk localised/locally advanced prostate cancer with a breast cancer gene mutation (BRCAm)....
Phase 3
Seoul, Korea, Republic of and 113 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Seoul, Korea, Republic of and 131 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Seoul, Korea, Republic of and 54 other locations
A phase 3, multi-center, single-group, open-label study to evaluate the efficacy and safety of DKF-MA102 in patients with prostate cancer...
Phase 3
Seoul, Korea, Republic of
plus prednisone in participants with metastatic castration resistant prostate cancer. Prednisolone may be used instead of prednison...
Phase 2, Phase 3
Seoul, Seoul-teukbyeolsi [Seoul], Korea, Republic of and 112 other locations
The main objective of the study is to compare overall survival in participants receiving xaluritamig versus investigator's choice (cabazitaxel or sec...
Phase 3
Seoul, Korea, Republic of and 84 other locations
second-line androgen receptor (AR) directed therapy with enzalutamide or docetaxel (chemotherapy) for treating metastatic castration-resistant prostate...
Phase 3
Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of and 182 other locations
examination to determine the presence of recurrent or metastatic prostate cancer in patients whose recurrent or metastatic lesions ...
Phase 3
Seoul, Korea, Republic of and 5 other locations
Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a ...
Phase 3
Seoul, Korea, Republic of and 8 other locations
Clinical trials
Research sites
Resources
Legal